Overall, the altered DNA methylation landscape has a central role in cancer, and targeting the epigenetic modifiers (e.g., DNMTs) and modulators (e.g., IDH1/2) involved in DNA methylation regulation can provide an avenue to modify cancer-associated transcriptional changes. Here, IDH1 is linked to cancer.